Chips

泛林称零部件短缺压低指引,Ichor 11月2日财报检验供应瓶颈

泛林集团刚交出创纪录的一季业绩,却仍警告零部件短缺压低了12月季度指引。11月2日Ichor发布财报,其阀门和线缆正是这轮供应紧缺中最窄的关口。

阅读原文

Vincent JiangVincent Jiang · 2 min read
Share
泛林集团首席执行官蒂姆·阿彻
1 / 6Slide 1 of 6
泛林集团首席执行官蒂姆·阿彻表示,当前的零部件紧张与新冠疫情时期的短缺不可同日而语,公司很快就能补上进度。

瓶颈出在阀门和线缆。10月21日,全球最大的刻蚀与沉积设备制造商泛林集团(Lam Research)−0.28% — 泛林集团(Lam Research), down 0.28 percent today公布9月季度营收82.2亿美元,创历史新高,非GAAP每股收益2.20美元,股价仍下跌9%,至236.83美元3。原因藏在首席财务官道格·贝丁格(Doug Bettinger)的一句话里:12月季度营收指引为86亿美元,上下浮动4亿美元,若非近期供应链出现一些制约,本可以更高一点3。问题不在需求,而在零部件。

同样被卡住脖子的小公司

两天后,市场就会听到这句话的小公司版本。Ichor Holdings+0.21% — Ichor Holdings, up 0.21 percent today总部位于加利福尼亚州弗里蒙特,生产焊装在泛林等客户晶圆制造设备中的气体与化学品输送子系统,将于2026年11月2日发布9月季度财报12。公司此前给出的指引为:营收3.15亿至3.45亿美元,非GAAP每股收益0.40至0.50美元;市场一致预期约为每股0.45美元12。

营收逐季攀升,6月季度仍因零部件短缺未达预期

  • 营收
  • Estimate
$0M$100M$200M$300M$400M2025年四季度2026年一季度2026年二季度2026年三季度指引(中值)$294.8M
Data
营收
2025年四季度$223.6M
2026年一季度$256.1M
2026年二季度$294.8M
2026年三季度指引(中值) (estimate)$330M
营收逐季攀升,6月季度仍因零部件短缺未达预期1,2

6月季度的表现,已经让人见识到零部件瓶颈的威力。由于零星零部件短缺,Ichor未能在季度结束前确认全部预期收入,当季营收虽同比增长24%、达到2.948亿美元,仍较一致预期低了1.85%2。这批出货几天后才落地,否则截至7月3日的13周营收本可突破3亿美元2。10月14日,奥本海默(Oppenheimer)警告称,从线缆到阀门,零部件供应依然不均衡,这波波折可能还会延续5。10月19日,B. Riley将目标价从105美元下调至85美元,维持买入评级6。

8月以来悉数被套

进入10月,供应紧缺雪上加霜。10月13日,投资者对设备板块全面获利了结:应用材料+0.32% — 应用材料, up 0.32 percent today下跌7%,泛林集团与KLA−1.71% — KLA, down 1.71 percent today下跌4%,同期半导体ETF仅下跌1%4。Ichor跌得比它们更惨。该股收报37.94美元,较113.58美元的52周高点低67%1;6月季度那轮增发中,Ichor以80.70美元的均价售出250万股,买家无一例外被套2。过去一年,公司内部人士卖出1300万美元,买入30万美元78。

短缺本身就是多头逻辑

反方论据是公开记录中最有力的一条。泛林集团首席执行官蒂姆·阿彻称,当前的供应紧张与疫情时期的短缺不可同日而语,公司很快就能补上进度;与此同时,业内流传的2027年设备支出规模超过2000亿美元3。需求景气中的短缺,既压制了眼下的出货,也把定价权交到明天能交货的企业手中。11月2日的财报将揭晓,阀门和线缆在这场交易中会落在哪一边3。

Get Chips by email, free

How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.

Loading LRCX…

Reader comments

0 comments

    Chips

    CXMT's profit rose just 1% to 4% on 15% to 20% more sales; SK hynix reports October 28

    China's biggest DRAM maker earned almost nothing more on 15-20% more sales, and its supplier filed that price increases are shrinking. SK hynix's October 28 print decides whether that is a CXMT cost story or the memory cycle's first crack.

    Chips

    FormFactor's revenue passed its own $225 million quarterly ceiling; it opened a Texas plant and fell 15.3%

    FormFactor opened its Texas probe-card plant the same day its stock fell 15%, with revenue already past the $225 million quarterly ceiling management set in February. Teradyne, now a $300 million shareholder, reports on October 27 with a guide below its own record.

    Chips

    Intel's $20 billion stock sale at $95, first since 1971, left buyers underwater before the October 29 report

    Intel raised $20 billion at $95 a share in August, its first public sale since 1971, and closed October 23 at $86.96, leaving the chief executive's own purchase about $846,000 underwater. Thursday's third-quarter report must set 2027 capital spending, and no 14A customer has published an order.

    Chips

    OpenAI now decides what Cerebras's wafer is worth

    Cerebras proved this month that its wafer serves trillion-parameter models fast, and the model it showcased was open-weights, not OpenAI's. With about $20 billion of $25 billion in contracted business tied to OpenAI and the last lock-ups expiring before the November 12 report, one buyer now sets the wafer's price.

    Chips

    SK Hynix killed Solidigm's IPO; US NAND fab has no named funding plan and Dalian's license ends December 31

    SK hynix killed the Solidigm Nasdaq float on October 23, six days before its earnings call, leaving the promised US NAND fab without a named funding plan just as Washington holds the Dalian licenses it was meant to buy.

    Chips

    Nvidia pays Ibiden, Samsung Electro-Mechanics and Unimicron for substrate capacity; AT&S fell 18.6%

    Nvidia is paying Ibiden, Samsung Electro-Mechanics and Unimicron to reserve production of the substrates that sit under its AI chips. AT&S, the Austrian substrate maker absent from Nvidia's list, is building the same capacity on AMD's and Marvell's commitments, and its stock sits 43% below its high with half-year results due on November 5.

    Get the newsletter

    The day's AI and market news, in your inbox every weekday.